ClinicalTrials.gg
CompletedNCT06280547KAPUpdated Jan 24, 2025

The Effect of Oral Health Education on Knowledge, Attitude, Practice and Dental Caries Among Egyptian School Children

An observational study in Dental Caries in Children and Knowledge, Attitudes, Practice, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-24.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
115
Ages
6 Years to 15 Years
Sex
All
01

Study summary

Aim of the study Assessing the effect of an oral health education program on knowledge, attitude, practice, and dental caries among a group of school children in a governmental school in Fayoum, Egypt.

Read the detailed description

Study type Others: Observational Before and after study

02

Conditions studied

  • Dental Caries in Children
  • Knowledge, Attitudes, Practice

Browse trials for

Keywords

  • dental caries in children
  • Knowledge, attitude and practice
  • dental caries experience
  • oral health education
03

In context

Behavior

406 studies on the registry are indexed under Behavior; 167 are open to participants now.

This study's enrollment of 115 is below the median of 250 across 81 observational studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

A group of Egyptian children aged between 6-15 years attending a public school in Fayoum

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • School children aged (6 to15) years old.
  • Children with or without previous dental experience.

Exclusion criteria

Exclusion Criteria:

  • Refusal of participation.
  • Children with a mental or physical disability
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
115 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • School children aged 6-15 years old

    School children aged (6 to15) years old. Children with or without previous dental experience. Children who agree to participate in the study along with a parent/guardian consent. Children without any mental or physical disabilities.

    Other: Oral health education

Interventions

  • OtherOral health education

    Oral Health Education Program performed in the school.

06

What researchers measure

Primary outcomes

  1. Oral health related attitude

    Measured by close ended questionnaire, the unit of measurement is binary and the higher score is related to a positive attitude

    Time frame: 6 months

Secondary outcomes

  1. Change in oral health related Knowledge, attitude and practice

    Measured by close ended questionnaire, the unit of measurement is binary and the higher score is related to a positive knowledge, attitude and practice accordingly

    Time frame: 6 months

Other outcomes

  1. Caries experience

    Measured using The Caries Assessment Spectrum and Treatment (CAST) index and the unit of measurement is percentage

    Time frame: 6 months

07

Study locations

1 site
  • Cairo University Faculty of Dentistry
    Cairo, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Oct 2024, 14 months.

Of 36 observational studies under Behavior, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 9. This study's 14 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2024
First posted
Feb 28, 2024
StartActual
Jul 30, 2023
Primary completionActual
Oct 15, 2024
CompletionActual
Dec 25, 2024
Last update
Jan 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06280547
Lead sponsor
Cairo University
Responsible party
Rana Hassan Ismail Ewaida (principle investigator, Cairo University) — Principal investigator
First posted
Feb 28, 2024
Start date
Jul 30, 2023
Primary completion
Oct 15, 2024
Completion
Dec 25, 2024
Last update
Jan 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion